Current Report Filing (8-k)

Date : 05/01/2019 @ 6:42PM
Source : Edgar (US Regulatory)
Stock : Pressure Biosciences, Inc. (QB) (PBIO)
Quote : 0.8  0.05 (6.67%) @ 9:45PM

Current Report Filing (8-k)

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

Current Report Pursuant

to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) April 25, 2019

 

PRESSURE BIOSCIENCES, INC.
(Exact Name of Registrant as Specified in its Charter)

 

MASSACHUSETTS
(State or Other Jurisdiction of Incorporation)

 

001-38185   04-2652826

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

14 Norfolk Avenue, South Easton, MA   02375
(Address of Principal Executive Offices)   (Zip Code)

 

(508) 230-1828
(Registrant’s Telephone Number, Including Area Code)

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company [  ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

 

 

     
 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Departure of Officer and Designation of Successor

 

On April 25, 2019, Mr. Richard T. Schumacher, President and Chief Executive Officer (“CEO”) of Pressure BioSciences, Inc. (the “Company”) informed the Company’s Board of Directors (the “Board”) that he plans to step down as President and CEO, effective September 9, 2019. Mr. Schumacher is expected to continue to serve as a member of the Board. After September 9, 2019, Mr. Schumacher is expected to serve as a senior consultant to the Company for at least one year.

 

On May 1, 2019, the Company announced that the Board has designated Bradford A. Young, Ph.D., MBA to succeed Mr. Schumacher as the Company’s President and CEO, effective September 9, 2019. Dr. Young has been the Company’s Senior Vice President and Chief Commercial Officer since November 2018. A copy of the press release announcing Mr. Schumacher’s transition to a new role and Dr. Young’s designation is furnished as Exhibit 99.1 to this report.

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

 

Exhibit

Number

  Exhibit Description
     
99.1   Press release issued by Pressure BioSciences, Inc. dated May 1, 2019.

 

     
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: May 1, 2019 PRESSURE BIOSCIENCES, INC.
   
  By:

/s/ Richard T. Schumacher

    Richard T. Schumacher,
    President and Chief Executive Officer

 

     
 

 

Pressure BioSciences, Inc. (USOTC:PBIO)
Historical Stock Chart

1 Year : From Dec 2018 to Dec 2019

Click Here for more Pressure BioSciences, Inc. Charts.

Pressure BioSciences, Inc. (USOTC:PBIO)
Intraday Stock Chart

Today : Saturday 7 December 2019

Click Here for more Pressure BioSciences, Inc. Charts.

Latest PBIO Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.